Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. - Wikidata - wikimedia - TriplyDB

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.

http://www.wikidata.org/entity/Q44082558

about

Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25 Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series)Optimization of cardiac metabolism in heart failure Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study Mitochondria in heart failure Prediction of marker genes associated with hypertension by bioinformatics analyses Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo What we know and do not know about sex and cardiac disease.Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors.Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study.The gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart.Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.Conditional PPARγ knockout from cardiomyocytes of adult mice impairs myocardial fatty acid utilization and cardiac function.An analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction with decreased cholinergic neurotransmission.CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism Modulating fatty acid oxidation in heart failure.Persistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in mice Nanoscale three-dimensional imaging of the human myocyte.Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes.Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters.Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?5'-AMP Activated Protein Kinase is Involved in the Regulation of Myocardial β-Oxidative Capacity in Mice.Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding Mitochondrial energy metabolism in heart failure: a question of balance.Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated Cardiomyopathy The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium.The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart.Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.AMP-activated protein kinase: Role in metabolism and therapeutic implications.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Heart in diabetes: not only a macrovascular disease.

P2860

Q21134128-2F520D3E-310D-4629-B783-2A8131FCDC45 Q26825047-12E5D1D9-867D-44DE-850E-10FF1E208911 Q27023021-B1346AFC-885D-442E-8314-3DC2932F1E58 Q27312512-2C8FFF9F-B5A9-4331-B87C-0F2482E1E5B3 Q28385915-541937E6-956B-4EE0-AD43-57803E221585 Q33783952-38F42224-E465-483D-B322-CC5E5489488F Q33784459-754CECF2-0415-48E3-816E-93E3E5210138 Q33812503-850BD23F-840B-4CFF-AAF9-936E7D7D74D2 Q33890891-74964066-DF6D-4869-830A-CA6D4EDD1123 Q33917163-FAB2AB6F-B939-4A1E-ACA8-91260733ECBD Q33917887-31110C46-130C-479B-B6F4-E1320D576DB9 Q33986863-A2EF9202-22E7-4776-95C4-ADF22533441D Q33991754-7105E385-35BA-41EA-A856-B7D836CED89E Q34310253-57B434EE-68D0-474D-9A54-3745113B5B27 Q34328505-5962D6AC-208B-448C-B460-8D804B753DA8 Q34396816-7CDDE537-82EC-43E9-8446-EE17C74C541C Q34808505-C30F1521-A9C3-4945-9582-EF22C1C7A252 Q34951279-912D5A99-C8A9-4FF2-A483-AA34CEB5ECFC Q34966915-1CD93A7B-1D43-4072-89B5-86966FAFBDFC Q35045900-8AA17CC1-B9CB-4D73-94C9-F9DB92EBF4D3 Q35283356-E34D03ED-2020-4444-9793-C3EB64874D0D Q35543414-B2AD9742-A7FC-4C43-8106-09255750E4B3 Q35624670-01C0C19B-AF5D-4B5E-B591-6CB726FA8BCE Q35667311-6AF56257-7466-45D8-AE4C-1DFF57EB3FEF Q35672804-3E48B1DD-CB87-468F-8416-234687B87DBF Q35761448-884DEF74-8A7B-4586-A20C-21E49B2033B0 Q35771294-7518C1E2-44CF-4245-9B96-1F1F7E7C23EE Q35918043-E30435AB-7467-4543-86C6-632CBAF154F1 Q35964903-57C2F6A8-6374-4CD7-8BDE-7A427BC594B3 Q36024334-627DA0C8-98EE-498A-8814-A1C47FDD12ED Q36070074-642D223D-3A21-458C-BCFB-008FCE663B2D Q36171264-C6967428-FFFD-4592-83BC-47BC88172471 Q36424416-C4CA82C4-E523-4700-A666-C12E51D40A03 Q36426768-4E765DB2-F947-47FA-B312-C70E8BDD3A9D Q36512000-4E8CF17E-BBE7-4208-B080-1DA7159B520B Q36540577-C5ABFFC9-A804-4145-B4BD-39269F200A5D Q36605039-A842EC33-B728-4CFC-974D-0C562F2A5F8E Q36616554-65887714-502C-4D4B-AA8C-30F365624617 Q36682368-C24446B7-9C4A-4EFF-9CEB-A4FF8409C49E Q36783718-9C4D7EF2-6C08-4D3A-B8C5-3531198E40D3

P2860

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.

http://www.wikidata.org/entity/Q44082558

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@en

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@nl

type

label

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@en

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@nl

prefLabel

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@en

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@nl

P1433

Q44082558-1F4FC68B-8041-4CCF-91BA-205AF31A47E5

P1476

Q44082558-083CEEDD-7258-492B-87E5-CC5130BA2780

P2093

Q44082558-007B89F8-84E4-4CBD-A115-3779D03A799E

Q44082558-0087DA2F-45E7-4301-88CF-CB603742066E

Q44082558-18D8BFCB-62EF-4FF0-B80D-F89FE6E4F1A3

Q44082558-25009FDB-2BA1-4A8B-9992-4DAC7B44F9AE

Q44082558-3A463E63-B712-4DB3-81C6-19FE8F0748C9

Q44082558-6B7C74C9-6AB0-4781-814C-9513EA7011F2

Q44082558-7667C46D-02EE-453A-BD3C-66F805B1E572

Q44082558-D60E7DC8-9C23-40DD-B2E2-3E8D9C438EA0

Q44082558-E3E22F8D-A243-4249-880E-1AE0535259A7

P304

Q44082558-769CD4DA-F4B2-44DC-8114-ECC53DED0E60

P31

Q44082558-0053B574-45D7-44DC-9DB8-1F37FDC6D076

P356

Q44082558-246A105B-5E63-4F60-ABB6-44F21A6D617F

P407

Q44082558-E07ADEEA-0077-4FB5-AB0C-2A01A671DAE3

P433

Q44082558-B79D4197-7520-4AD4-BCE6-4C1942B8898E

P478

Q44082558-B9C40D08-97E2-4782-A3A3-0A13B32FB45F

P577

Q44082558-4BEB3371-B40F-432D-8A3D-727FEE5E4583

P698

Q44082558-F8A58E2D-6035-420E-ADDF-7F4B6E6F6E89

P921

Q44082558-538737A0-0492-4373-B87D-6EB831AB512B

Q44082558-821F07C0-4E52-4190-87EF-982546BF8BAE

P356

01.CIR.0000023531.22727.C1

P1433

P1476

Impaired myocardial fatty acid ...... pacing-induced heart failure.

@en

P2093

Ashish R Panchal

http://www.w3.org/2001/XMLSchema#string

Axel Linke

http://www.w3.org/2001/XMLSchema#string

Fabio A Recchia

http://www.w3.org/2001/XMLSchema#string

Gary D Lopaschuk

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Osorio

http://www.w3.org/2001/XMLSchema#string

Michele Castellari

http://www.w3.org/2001/XMLSchema#string

Quy N Diep

http://www.w3.org/2001/XMLSchema#string

Thomas H Hintze

http://www.w3.org/2001/XMLSchema#string

William C Stanley

http://www.w3.org/2001/XMLSchema#string

P304

606-612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000023531.22727.C1

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12147544

http://www.w3.org/2001/XMLSchema#string

P921